Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule.

Case reports in oncology

Ota S, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Sasajima Y, Seki N.
PMID: 29515403
Case Rep Oncol. 2018 Jan 04;11(1):11-16. doi: 10.1159/000484976. eCollection 2018.

The patient was a 66-year-old woman. An induration of approximately 15 mm in size that accompanied redness was palpable in the umbilical fossa. She did not respond to 1-month antibiotic treatment provided by the previous physician. For this reason,...

Cite
Ota S, Haruyama T, Ishihara M, et al. A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule. Case Rep Oncol. 2018;11(1):11-16doi: 10.1159/000484976.
Ota, S., Haruyama, T., Ishihara, M., Natsume, M., Fukasawa, Y., Sakamoto, T., Tanzawa, S., Usui, R., Honda, T., Ichikawa, Y., Watanabe, K., Sasajima, Y., & Seki, N. (2018). A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule. Case reports in oncology, 11(1), 11-16. https://doi.org/10.1159/000484976
Ota, Shuji, et al. "A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule." Case reports in oncology vol. 11,1 (2018): 11-16. doi: https://doi.org/10.1159/000484976
Ota S, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Sasajima Y, Seki N. A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule. Case Rep Oncol. 2018 Jan 04;11(1):11-16. doi: 10.1159/000484976. eCollection 2018. PMID: 29515403; PMCID: PMC5836228.
Copy Download .nbib Format: NLM
[Social background and life events in depression].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

Natsume M.
PMID: 20455305
Seishin Shinkeigaku Zasshi. 2010;112(3):211-7.

No abstract available.

Cite
Natsume M. [Social background and life events in depression]. Seishin Shinkeigaku Zasshi. 2010;112(3):211-7
Natsume, M. (2010). [Social background and life events in depression]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 112(3), 211-7.
Natsume, Makoto. "[Social background and life events in depression]." Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica vol. 112,3 (2010): 211-7.
Natsume M. [Social background and life events in depression]. Seishin Shinkeigaku Zasshi. 2010;112(3):211-7. Japanese. PMID: 20455305.
Copy Download .nbib Format: NLM
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.

Case reports in oncology

Seki N, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K.
PMID: 30792647
Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019.

Common dermatological side-effects associated with erlotinib, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), include pruritus and skin rash, which are mediated by substance P, leading to the occasional discontinuation of cancer treatment. Aprepitant is an antagonist of...

Cite
Seki N, Ochiai R, Haruyama T, et al. Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush. Case Rep Oncol. 2019;12(1):84-90doi: 10.1159/000493256.
Seki, N., Ochiai, R., Haruyama, T., Ishihara, M., Natsume, M., Fukasawa, Y., Sakamoto, T., Tanzawa, S., Usui, R., Honda, T., Ota, S., Ichikawa, Y., & Watanabe, K. (2019). Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush. Case reports in oncology, 12(1), 84-90. https://doi.org/10.1159/000493256
Seki, Nobuhiko, et al. "Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush." Case reports in oncology vol. 12,1 (2019): 84-90. doi: https://doi.org/10.1159/000493256
Seki N, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K. Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush. Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019. PMID: 30792647; PMCID: PMC6381921.
Copy Download .nbib Format: NLM
Ultrasonic Mist Generation Assist Argon-Nitrogen Mix Gas Effect on Radioactive Strontium Quantification by Online Solid-Phase Extraction with Inductively Coupled Plasma Mass Spectrometry.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry

Furukawa M, Matsueda M, Takagai Y.
PMID: 29563355
Anal Sci. 2018 Apr 10;34(4):471-476. doi: 10.2116/analsci.17P483. Epub 2018 Mar 20.

The Ar-N

Cite
Furukawa M, Matsueda M, Takagai Y. Ultrasonic Mist Generation Assist Argon-Nitrogen Mix Gas Effect on Radioactive Strontium Quantification by Online Solid-Phase Extraction with Inductively Coupled Plasma Mass Spectrometry. Anal Sci. 2018;34(4):471-476doi: 10.2116/analsci.17P483.
Furukawa, M., Matsueda, M., & Takagai, Y. (2018). Ultrasonic Mist Generation Assist Argon-Nitrogen Mix Gas Effect on Radioactive Strontium Quantification by Online Solid-Phase Extraction with Inductively Coupled Plasma Mass Spectrometry. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 34(4), 471-476. https://doi.org/10.2116/analsci.17P483
Furukawa, Makoto, et al. "Ultrasonic Mist Generation Assist Argon-Nitrogen Mix Gas Effect on Radioactive Strontium Quantification by Online Solid-Phase Extraction with Inductively Coupled Plasma Mass Spectrometry." Analytical sciences : the international journal of the Japan Society for Analytical Chemistry vol. 34,4 (2018): 471-476. doi: https://doi.org/10.2116/analsci.17P483
Furukawa M, Matsueda M, Takagai Y. Ultrasonic Mist Generation Assist Argon-Nitrogen Mix Gas Effect on Radioactive Strontium Quantification by Online Solid-Phase Extraction with Inductively Coupled Plasma Mass Spectrometry. Anal Sci. 2018 Apr 10;34(4):471-476. doi: 10.2116/analsci.17P483. Epub 2018 Mar 20. PMID: 29563355.
Copy Download .nbib Format: NLM
Case of pancreatic metastasis from colon cancer in which cell block using the Trefle.

World journal of gastrointestinal oncology

Kato A, Naitoh I, Kato H, Hayashi K, Miyabe K, Yoshida M, Hori Y, Natsume M, Jinno N, Yanagita T, Takiguchi S, Takahashi S, Joh T.
PMID: 29564039
World J Gastrointest Oncol. 2018 Mar 15;10(3):91-95. doi: 10.4251/wjgo.v10.i3.91.

Endoscopic transpapillary brush cytology and forceps biopsy during endoscopic retrograde cholangiopancreatology are generally used to obtain pathological evidence of biliary strictures. Recently, the new endoscopic scraper Trefle

Cite
Kato A, Naitoh I, Kato H, et al. Case of pancreatic metastasis from colon cancer in which cell block using the Trefle. World J Gastrointest Oncol. 2018;10(3):91-95doi: 10.4251/wjgo.v10.i3.91.
Kato, A., Naitoh, I., Kato, H., Hayashi, K., Miyabe, K., Yoshida, M., Hori, Y., Natsume, M., Jinno, N., Yanagita, T., Takiguchi, S., Takahashi, S., & Joh, T. (2018). Case of pancreatic metastasis from colon cancer in which cell block using the Trefle. World journal of gastrointestinal oncology, 10(3), 91-95. https://doi.org/10.4251/wjgo.v10.i3.91
Kato, Akihisa, et al. "Case of pancreatic metastasis from colon cancer in which cell block using the Trefle." World journal of gastrointestinal oncology vol. 10,3 (2018): 91-95. doi: https://doi.org/10.4251/wjgo.v10.i3.91
Kato A, Naitoh I, Kato H, Hayashi K, Miyabe K, Yoshida M, Hori Y, Natsume M, Jinno N, Yanagita T, Takiguchi S, Takahashi S, Joh T. Case of pancreatic metastasis from colon cancer in which cell block using the Trefle. World J Gastrointest Oncol. 2018 Mar 15;10(3):91-95. doi: 10.4251/wjgo.v10.i3.91. PMID: 29564039; PMCID: PMC5852400.
Copy Download .nbib Format: NLM
Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.

BMJ open

Inoue S, Watanuki Y, Kaneko T, Sato T, Miyazawa N, Kaneko T, Ishigatsubo Y, Morita S, Natsumeda Y, Mizushima S.
PMID: 22021764
BMJ Open. 2011 Jul 18;1(1):e000105. doi: 10.1136/bmjopen-2011-000105.

OBJECTIVE: To determine the ideal conditions for use of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older outpatients with chronic pulmonary diseases.DESIGN: Prospective cohort study.PARTICIPANTS: 1378 outpatients with chronic pulmonary diseases ≥ 60 years of age.INTERVENTION: Participants were educated...

Cite
Inoue S, Watanuki Y, Kaneko T, et al. Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study. BMJ Open. 2011;1(1):e000105doi: 10.1136/bmjopen-2011-000105.
Inoue, S., Watanuki, Y., Kaneko, T., Sato, T., Miyazawa, N., Kaneko, T., Ishigatsubo, Y., Morita, S., Natsumeda, Y., & Mizushima, S. (2011). Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study. BMJ open, 1(1), e000105. https://doi.org/10.1136/bmjopen-2011-000105
Inoue, Satoshi, et al. "Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study." BMJ open vol. 1,1 (2011): e000105. doi: https://doi.org/10.1136/bmjopen-2011-000105
Inoue S, Watanuki Y, Kaneko T, Sato T, Miyazawa N, Kaneko T, Ishigatsubo Y, Morita S, Natsumeda Y, Mizushima S. Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study. BMJ Open. 2011 Jul 18;1(1):e000105. doi: 10.1136/bmjopen-2011-000105. PMID: 22021764; PMCID: PMC3191416.
Copy Download .nbib Format: NLM
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.

International journal of clinical oncology

Asano K, Yamashita Y, Ono T, Natsumeda M, Beppu T, Matsuda K, Ichikawa M, Kanamori M, Matsuzaka M, Kurose A, Saito K, Sonoda Y, Ogasawara K, Fujii Y, Shimizu H, Ohkuma H, Kitanaka C, Kayama T, Tominaga T.
PMID: 34637053
Int J Clin Oncol. 2022 Jan;27(1):77-94. doi: 10.1007/s10147-021-02042-3. Epub 2021 Oct 12.

BACKGROUND: Elderly patients with primary central nervous system malignant lymphoma (EL-PCNSL) may not be given sufficient treatment due to their poor pre-treatment Karnofsky Performance Status (KPS) and comorbidities. Therefore, a retrospective, cohort study was performed to evaluate risk factors...

Cite
Asano K, Yamashita Y, Ono T, et al. The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group. Int J Clin Oncol. 2021;27(1):77-94doi: 10.1007/s10147-021-02042-3.
Asano, K., Yamashita, Y., Ono, T., Natsumeda, M., Beppu, T., Matsuda, K., Ichikawa, M., Kanamori, M., Matsuzaka, M., Kurose, A., Saito, K., Sonoda, Y., Ogasawara, K., Fujii, Y., Shimizu, H., Ohkuma, H., Kitanaka, C., Kayama, T., & Tominaga, T. (2022). The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group. International journal of clinical oncology, 27(1), 77-94. https://doi.org/10.1007/s10147-021-02042-3
Asano, Kenichiro, et al. "The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group." International journal of clinical oncology vol. 27,1 (2022): 77-94. doi: https://doi.org/10.1007/s10147-021-02042-3
Asano K, Yamashita Y, Ono T, Natsumeda M, Beppu T, Matsuda K, Ichikawa M, Kanamori M, Matsuzaka M, Kurose A, Saito K, Sonoda Y, Ogasawara K, Fujii Y, Shimizu H, Ohkuma H, Kitanaka C, Kayama T, Tominaga T. The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group. Int J Clin Oncol. 2022 Jan;27(1):77-94. doi: 10.1007/s10147-021-02042-3. Epub 2021 Oct 12. PMID: 34637053.
Copy Download .nbib Format: NLM
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy.

Neuro-oncology advances

Kanamori M, Takami H, Suzuki T, Tominaga T, Kurihara J, Tanaka S, Hatazaki S, Nagane M, Matsuda M, Yoshino A, Natsumeda M, Yamaoka M, Kagawa N, Akiyama Y, Fukai J, Negoto T, Shibahara I, Tanaka K, Inoue A, Mase M, Tomita T, Kuga D, Kijima N, Fukami T, Nakahara Y, Natsume A, Yoshimoto K, Keino D, Tokuyama T, Asano K, Ujifuku K, Abe H, Nakada M, Matsuda KI, Arakawa Y, Ikeda N, Narita Y, Shinojima N, Kambe A, Nonaka M, Izumoto S, Kawanishi Y, Kanaya K, Nomura S, Nakajima K, Yamamoto S, Terashima K, Ichimura K, Nishikawa R.
PMID: 34355172
Neurooncol Adv. 2021 Jun 25;3(1):vdab086. doi: 10.1093/noajnl/vdab086. eCollection 2021.

BACKGROUND: Cerebrospinal fluid (CSF) cytology and spinal MR imaging are routinely performed for staging before treatment of intracranial germinoma. However, the interpretation of the results of CSF cytology poses 2 unresolved clinical questions: (1) Does positive CSF cytology correlate...

Cite
Kanamori M, Takami H, Suzuki T, et al. Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. Neurooncol Adv. 2021;3(1):vdab086doi: 10.1093/noajnl/vdab086.
Kanamori, M., Takami, H., Suzuki, T., Tominaga, T., Kurihara, J., Tanaka, S., Hatazaki, S., Nagane, M., Matsuda, M., Yoshino, A., Natsumeda, M., Yamaoka, M., Kagawa, N., Akiyama, Y., Fukai, J., Negoto, T., Shibahara, I., Tanaka, K., Inoue, A., Mase, M., Tomita, T., Kuga, D., Kijima, N., Fukami, T., Nakahara, Y., Natsume, A., Yoshimoto, K., Keino, D., Tokuyama, T., Asano, K., Ujifuku, K., Abe, H., Nakada, M., Matsuda, K. I., Arakawa, Y., Ikeda, N., Narita, Y., Shinojima, N., Kambe, A., Nonaka, M., Izumoto, S., Kawanishi, Y., Kanaya, K., Nomura, S., Nakajima, K., Yamamoto, S., Terashima, K., Ichimura, K., & Nishikawa, R. (2021). Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. Neuro-oncology advances, 3(1), vdab086. https://doi.org/10.1093/noajnl/vdab086
Kanamori, Masayuki, et al. "Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy." Neuro-oncology advances vol. 3,1 (2021): vdab086. doi: https://doi.org/10.1093/noajnl/vdab086
Kanamori M, Takami H, Suzuki T, Tominaga T, Kurihara J, Tanaka S, Hatazaki S, Nagane M, Matsuda M, Yoshino A, Natsumeda M, Yamaoka M, Kagawa N, Akiyama Y, Fukai J, Negoto T, Shibahara I, Tanaka K, Inoue A, Mase M, Tomita T, Kuga D, Kijima N, Fukami T, Nakahara Y, Natsume A, Yoshimoto K, Keino D, Tokuyama T, Asano K, Ujifuku K, Abe H, Nakada M, Matsuda KI, Arakawa Y, Ikeda N, Narita Y, Shinojima N, Kambe A, Nonaka M, Izumoto S, Kawanishi Y, Kanaya K, Nomura S, Nakajima K, Yamamoto S, Terashima K, Ichimura K, Nishikawa R. Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. Neurooncol Adv. 2021 Jun 25;3(1):vdab086. doi: 10.1093/noajnl/vdab086. eCollection 2021. PMID: 34355172; PMCID: PMC8331051.
Copy Download .nbib Format: NLM
Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding.

Clinical endoscopy

Yoshida M, Inoue T, Naitoh I, Hayashi K, Hori Y, Natsume M, Atsuta N, Kataoka H.
PMID: 33207403
Clin Endosc. 2020 Nov 19; doi: 10.5946/ce.2020.217. Epub 2020 Nov 19.

We reviewed 7 patients with unsuccessful endoscopic hemostasis using covered self-expandable metal stent (CSEMS) placement for post-endoscopic sphincterotomy (ES) bleeding. ES with a medium incision was performed in 6 and with a large incision in 1 patient. All but...

Cite
Yoshida M, Inoue T, Naitoh I, et al. Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding. Clin Endosc. 2020;doi: 10.5946/ce.2020.217.
Yoshida, M., Inoue, T., Naitoh, I., Hayashi, K., Hori, Y., Natsume, M., Atsuta, N., & Kataoka, H. (2020). Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding. Clinical endoscopy, . https://doi.org/10.5946/ce.2020.217
Yoshida, Michihiro, et al. "Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding." Clinical endoscopy vol. (2020). doi: https://doi.org/10.5946/ce.2020.217
Yoshida M, Inoue T, Naitoh I, Hayashi K, Hori Y, Natsume M, Atsuta N, Kataoka H. Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding. Clin Endosc. 2020 Nov 19; doi: 10.5946/ce.2020.217. Epub 2020 Nov 19. PMID: 33207403.
Copy Download .nbib Format: NLM
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.

Diagnostics (Basel, Switzerland)

On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y.
PMID: 33918936
Diagnostics (Basel). 2021 Apr 09;11(4). doi: 10.3390/diagnostics11040681.

Recent studies have suggested the feasibility of detecting H3K27M mutations in the cerebrospinal fluid of diffuse midline glioma (DMG) patients. However, cerebrospinal fluid from patients in these studies were collected mainly during biopsy, ventriculo-peritoneal shunt procedures or postmortem. We...

Cite
On J, Natsumeda M, Watanabe J, et al. Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel). 2021;11(4)doi: 10.3390/diagnostics11040681.
On, J., Natsumeda, M., Watanabe, J., Saito, S., Kanemaru, Y., Abe, H., Tsukamoto, Y., Okada, M., Oishi, M., Yoshimura, J., Kakita, A., & Fujii, Y. (2021). Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel, Switzerland), 11(4), . https://doi.org/10.3390/diagnostics11040681
On, Jotaro, et al. "Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas." Diagnostics (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/diagnostics11040681
On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y. Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas. Diagnostics (Basel). 2021 Apr 09;11(4). doi: 10.3390/diagnostics11040681. PMID: 33918936; PMCID: PMC8070169.
Copy Download .nbib Format: NLM
Online Solid-Phase Extraction-Inductively Coupled Plasma-Quadrupole Mass Spectrometry with Oxygen Dynamic Reaction for Quantification of Technetium-99.

ACS omega

Matsueda M, Yanagisawa K, Koarai K, Terashima M, Fujiwara K, Abe H, Kitamura A, Takagai Y.
PMID: 34337265
ACS Omega. 2021 Jul 16;6(29):19281-19290. doi: 10.1021/acsomega.1c02756. eCollection 2021 Jul 27.

Quantification of pg/L levels (i.e., 0.6 mBq/L) of radioactive technetium-99 (

Cite
Matsueda M, Yanagisawa K, Koarai K, et al. Online Solid-Phase Extraction-Inductively Coupled Plasma-Quadrupole Mass Spectrometry with Oxygen Dynamic Reaction for Quantification of Technetium-99. ACS Omega. 2021;6(29):19281-19290doi: 10.1021/acsomega.1c02756.
Matsueda, M., Yanagisawa, K., Koarai, K., Terashima, M., Fujiwara, K., Abe, H., Kitamura, A., & Takagai, Y. (2021). Online Solid-Phase Extraction-Inductively Coupled Plasma-Quadrupole Mass Spectrometry with Oxygen Dynamic Reaction for Quantification of Technetium-99. ACS omega, 6(29), 19281-19290. https://doi.org/10.1021/acsomega.1c02756
Matsueda, Makoto, et al. "Online Solid-Phase Extraction-Inductively Coupled Plasma-Quadrupole Mass Spectrometry with Oxygen Dynamic Reaction for Quantification of Technetium-99." ACS omega vol. 6,29 (2021): 19281-19290. doi: https://doi.org/10.1021/acsomega.1c02756
Matsueda M, Yanagisawa K, Koarai K, Terashima M, Fujiwara K, Abe H, Kitamura A, Takagai Y. Online Solid-Phase Extraction-Inductively Coupled Plasma-Quadrupole Mass Spectrometry with Oxygen Dynamic Reaction for Quantification of Technetium-99. ACS Omega. 2021 Jul 16;6(29):19281-19290. doi: 10.1021/acsomega.1c02756. eCollection 2021 Jul 27. PMID: 34337265; PMCID: PMC8320326.
Copy Download .nbib Format: NLM
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.

Frontiers in oncology

Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, Yoshimura J, Oishi M, Hashizume R, Kakita A, Fujii Y.
PMID: 32039031
Front Oncol. 2020 Jan 21;9:1568. doi: 10.3389/fonc.2019.01568. eCollection 2019.

Diffuse midline gliomas (DMGs) show resistance to many chemotherapeutic agents including temozolomide (TMZ). Histone gene mutations in DMGs trigger epigenetic changes including DNA hypomethylation, one of which is a frequent lack of O6-methyl-guanine-DNA methyltransferase (

Cite
Abe H, Natsumeda M, Okada M, et al. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Front Oncol. 2020;9:1568doi: 10.3389/fonc.2019.01568.
Abe, H., Natsumeda, M., Okada, M., Watanabe, J., Tsukamoto, Y., Kanemaru, Y., Yoshimura, J., Oishi, M., Hashizume, R., Kakita, A., & Fujii, Y. (2019). MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Frontiers in oncology, 91568. https://doi.org/10.3389/fonc.2019.01568
Abe, Hideaki, et al. "MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas." Frontiers in oncology vol. 9 (2019): 1568. doi: https://doi.org/10.3389/fonc.2019.01568
Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, Yoshimura J, Oishi M, Hashizume R, Kakita A, Fujii Y. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Front Oncol. 2020 Jan 21;9:1568. doi: 10.3389/fonc.2019.01568. eCollection 2019. PMID: 32039031; PMCID: PMC6985080.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries